Evobrutinib
merck
['ease', 'marker ']
new data suggests that gfap may be a more reliable biomarker to track ms disease progression than neurofilament light. #ectrims2022 read more on the findings from jens kuhle, md, et al: 
Delivering healthcare professionals treating neurological diseases quality and relevant information to help achieve the best patient care possible. #MindMoments